Inoviq Ltd has released a press release.
BARD1 Appoints New CSO
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Inoviq
- BARD1 Share Purchase Plan Completed Oversubscribed
- Proof-of-Concept for SubB2M ELISA-Based Ovarian Cancer Test
- BARD1 lodges spp and options prospectus
- BARD1 Collaborator Uni of QLD Announces Ovarian Cancer Data
- Updated Investor Presentation
Later from Inoviq
- AGM Presentation
- Appendix 4C & Quarterly Activities Report
- Brazilian Patent Issued for Lung & Colorectal Cancer
- Update on Legal Proceedings and BARD1 Autoantibody Program
- INOVIQ & UQ Collaborate on Exosome-based Ovarian Cancer Test
Follow Inoviq into a list and get an email when it puts out news.
Follow Inoviq